“Unetixs is pleased to offer a vascular system that follows the IDC practices and provides ergonomically enhanced features. It will give health care professionals the confidence to not only make ...
At 24 months, the target lesion primary patency (TLPP) 1 was 41.7% At 24 months, the access circuit primary patency (ACPP) 2 was 25.7% SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback